Physician- and patient-reported dermatologic comorbidities of hypermobile Ehlers-Danlos syndrome - 20/03/24
Doi : 10.1016/j.jaad.2023.11.036
Alan N. Snyder, MD, MSCR a, ⁎ 
, Almeera Lateef, BS b, Nicholas Strat, MSCR a, Laura Andrews, MD, MSCR a, Chelsea Shope, MD, MSCR a, Cortney Gensemer, PhD c, Bao Xin Liang, BS d, Taylor Petrucci, MS c, Mark Lavallee, MD e, Russel Norris, PhD c, Dirk Elston, MD a
, Almeera Lateef, BS b, Nicholas Strat, MSCR a, Laura Andrews, MD, MSCR a, Chelsea Shope, MD, MSCR a, Cortney Gensemer, PhD c, Bao Xin Liang, BS d, Taylor Petrucci, MS c, Mark Lavallee, MD e, Russel Norris, PhD c, Dirk Elston, MD a a Department of Dermatology and Dermatologic Surgery, Medical University of South Carolina, Charleston, South Carolina
b College of Medicine, Medical University of South Carolina, Charleston, South Carolina
c Department of Regenerative Medicine and Cell Biology, Medical University of South Carolina, Charleston, South Carolina
d John A. Burns School of Medicine, University of Hawai’i, Honolulu, Hawai’I
e Department of Orthopedics, University of Pittsburgh Medical Center, Central PA, Harrisburg, Pennsylvania
∗Correspondence to: Alan N. Snyder, MD, MSCR, 171 Ashley Avenue, Charleston, SC 29425171 Ashley AvenueCharlestonSC29425
Key words : connective tissue disease, Ehlers-Danlos syndrome
| Funding sources: This work was supported by Ehlers Danlos Society (RAN), and the Maltz Foundation (RAN). |
|
| IRB approval status: Not applicable. |
© 2023
American Academy of Dermatology, Inc.. Pubblicato da Elsevier Masson SAS. Tutti i diritti riservati.
Vol 90 - N° 4
P. 824-826 - aprile 2024 Ritorno al numero
Articolo precedente
- Implementation of Mohs micrographic surgery at the VA New York Manhattan Harbor Healthcare System eliminated need for re-excision and decreased time to treatment: A retrospective and prospective cohort study
- Jaclyn Rosenthal Himeles, Alexa Beth Steuer, Rachel Sally, Daniel Gutierrez, John G. Zampella, Mary L. Stevenson, John A. Carucci, Nayoung Lee
- Histopathological predictors of immune-related adverse events among patients with melanoma treated with immune checkpoint inhibitors
- Catherina X. Pan, Mofei Liu, Charles B. Lau, William C. Lau, Daniel Y. Kim, Shahin A. Saberi, Rachael Rowley, Ruhi Kanwar, Anita Giobbie-Hurder, Nicole R. LeBoeuf, Vinod E. Nambudiri
Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.
Già abbonato a @@106933@@ rivista ?